Comments
Biopharmaceuticals major Biocon has named Peter Bains as Group CEO. Bains assumed his new leadership role on Monday and will directly report to group chairperson Kiran Mazumdar-Shaw.
Bains was previously an independent director on Biocon’s board since December, and CEO and board director at Syngene International, a subsidiary of Biocon, from 2010-16.
He has over three decades of experience in strategic and operational leadership roles in various companies, including GSK, MiNA Therapeutics, and Indivior Plc.
He holds a BSc degree with combined honours in zoology and physiology from the University of Sheffield, UK.
“Peter has a unique fit and profile for the role, having both extensive global leadership experience and success across the biopharmaceutical field and a comprehensive understanding of the Biocon Group, having led Syngene for 5 years and taking it through its very successful IPO in 2015,” Shaw said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.